Moderna to develop seasonal flu vaccine

The drugmaker stated vaccines normally reduce the threat of getting the influenza by 40 percent to 60 percent and that high-risk groups would take advantage of a flu shot with greater efficacy.

More short articles on drug store: Drug expenses surge faster than any other medical excellent or service, information showsEli Lilly, Amgen partner to make Lillys COVID-19 antibody drugModerna will understand if COVID-19 vaccine works in November, CEO says.

Check out the full press release here..

Moderna said Sept. 17 that it will start developing a seasonal influenza vaccine..

Maia Anderson –
Friday, September 18th, 2020
Print|Email.

” We are increasing our investment in vaccines, and we will develop a seasonal influenza vaccine, offered the unmet requirement for highly reliable vaccines,” CEO Stephane Bancel said in a news release.

Between 9 million and 45 million people in the U.S. have actually passed away of the influenza every year since 2010, according to the CDC..

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by click on this link.